BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24629163)

  • 1. Changes in nuclear morphology and chromatin texture of basal keratinocytes in melasma.
    Brianezi G; Handel AC; Schmitt JV; Miot LD; Miot HA
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):809-12. PubMed ID: 24629163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melasma: histopathological characteristics in 56 Korean patients.
    Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
    Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.
    Gautam M; Patil S; Nadkarni N; Sandhu M; Godse K; Setia M
    Indian J Dermatol Venereol Leprol; 2019; 85(4):367-373. PubMed ID: 30516167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of keratinocytes in facial solar lentigo with flattened rete ridges: comparison with melasma.
    Shin J; Park JY; Kim SJ; Kang HY
    Clin Exp Dermatol; 2015 Jul; 40(5):489-94. PubMed ID: 25704166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo multiphoton microscopy of melasma.
    Lentsch G; Balu M; Williams J; Lee S; Harris RM; König K; Ganesan A; Tromberg BJ; Nair N; Santhanam U; Misra M
    Pigment Cell Melanoma Res; 2019 May; 32(3):403-411. PubMed ID: 30506627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural characterization of damage in the basement membrane of facial melasma.
    Espósito ACC; Brianezi G; de Souza NP; Santos DC; Miot LDB; Miot HA
    Arch Dermatol Res; 2020 Apr; 312(3):223-227. PubMed ID: 31531731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.
    Attwa E; Khater M; Assaf M; Haleem MA
    Int J Dermatol; 2015 Feb; 54(2):235-44. PubMed ID: 25266556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.
    Miot LD; Miot HA; Polettini J; Silva MG; Marques ME
    Am J Dermatopathol; 2010 Oct; 32(7):676-82. PubMed ID: 20534990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution.
    Kang HY; Bahadoran P; Suzuki I; Zugaj D; Khemis A; Passeron T; Andres P; Ortonne JP
    Exp Dermatol; 2010 Aug; 19(8):e228-33. PubMed ID: 20497220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fibroblast-derived factors in the pathogenesis of melasma.
    Byun JW; Park IS; Choi GS; Shin J
    Clin Exp Dermatol; 2016 Aug; 41(6):601-9. PubMed ID: 27416970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women.
    Tamega Ade A; Miot HA; Moço NP; Silva MG; Marques ME; Miot LD
    Int J Cosmet Sci; 2015 Apr; 37(2):222-8. PubMed ID: 25439299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-facial melasma: clinical, histopathological, and immunohistochemical case-control study.
    Ritter CG; Fiss DV; Borges da Costa JA; de Carvalho RR; Bauermann G; Cestari TF
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1088-94. PubMed ID: 22827850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study.
    Espósito ACC; Brianezi G; de Souza NP; Miot LDB; Marques MEA; Miot HA
    Int J Cosmet Sci; 2018 Aug; 40(4):420-424. PubMed ID: 29846953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.
    Torres-Álvarez B; Mesa-Garza IG; Castanedo-Cázares JP; Fuentes-Ahumada C; Oros-Ovalle C; Navarrete-Solis J; Moncada B
    Am J Dermatopathol; 2011 May; 33(3):291-5. PubMed ID: 21317614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
    Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
    Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinic lichen planus simulating melasma.
    Aloi F; Solaroli C; Giovannini E
    Dermatology; 1997; 195(1):69-70. PubMed ID: 9267745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.
    Grimes PE; Yamada N; Bhawan J
    Am J Dermatopathol; 2005 Apr; 27(2):96-101. PubMed ID: 15798432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A morphometric and immunohistochemical study of melanocytes in periorbital hyperpigmentation.
    Boruah D; Manu V; Malik A; Chatterjee M; Vasudevan B; Srinivas V
    Indian J Dermatol Venereol Leprol; 2015; 81(6):588-93. PubMed ID: 26515837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4, IL-17, and COX-2 Are Associated With Subclinical Inflammation in Malar Melasma.
    Rodríguez-Arámbula A; Torres-Álvarez B; Cortés-García D; Fuentes-Ahumada C; Castanedo-Cázares JP
    Am J Dermatopathol; 2015 Oct; 37(10):761-6. PubMed ID: 26381025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
    Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
    Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.